BLUE: bluebirdbio.com Expected earnings per share growth for next year

Bluebird Bio (BLUE) - corporate logo

The forward net income growth rate for bluebird bio, Inc. (BLUE) demonstrates a development vector supported by a strong staff of molecular biologists. The business relies on a distributed network of CDMO facilities to ensure stable drug production. A revolutionary one-time cure method for genetic pathologies creates a unique market advantage. The value of 0.00 reflects the baseline metric level, linking analyst expectations with the company's real potential.

BLUE: bluebird bio Inc. Net earnings per share growth forecast for next year 07/04/2022 - 06/07/2025

Metric breakdowns and analytics for Bluebird Bio (BLUE)

- share price and consensus valuation forecast:
Fundamental company valuation:bluebirdbio.com, BLUE
Core merchandise of bluebird bio Inc.

The projected earnings per share growth rate reflects the analysts' consensus assessment of the ability of bluebird bio, Inc. (BLUE) to increase profitability amid the high cost of gene therapy. The trend of this indicator measures the balance between market demand and inflation; however, for this company, it is limited by low margin scalability due to extreme unit costs associated with the personalized production of each drug dose.

Competitor analysis

TEM (Tempus) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year QGEN (Qiagen)|Earnings growth forecast for next year IONS|RGEN (Repligen) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year aviditybiosciences.com RNA|CRISPR (CRSP) - Expected net earnings per share growth next year|genedx.com - Earnings growth forecast for next year|Expected earnings per share trend next year RARE (ultragenyx.com)|BEAM: Earnings growth forecast for next year|Sarepta - Expected earnings per share trend next year|TWST (twistbioscience.com) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year TXG (10x Genomics Corp)|Earnings growth forecast for next year NTLA|Earnings growth forecast for next year Stoke Therapeutics, Inc. (STOK)|Net earnings per share growth forecast for next year BioLife BLFS|WVE - Expected earnings per share growth for next year|Maze Therapeutics Corp - Earnings growth forecast for next year|Sionna Pharma - Projected earnings per share increase next year|Prime Medicine (PRME) - Net earnings per share growth forecast for next year|tayshagtx.com (TSHA) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year uniQure Corp|MGTX: Expected earnings per share trend next year|Earnings growth forecast for next year RGNX|Consensus forecast of earnings per share growth for next year Solid Corp|Earnings growth forecast for next year OCGN (ocugen.com)|PACB (Pacific Biosciences) - Net earnings per share change forecast for next year|Benitec Biopharma Inc - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Design Therapeutics, Inc. DSGN|Rocket Corp (RCKT) - Net earnings per share growth forecast for next year|4D Molecular Therapeutics (FDMT) - Earnings growth forecast for next year|LXEO (Lexeo Therapeutics, Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year korrobio.com KRRO|Expected earnings per share growth for next year EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year ProQR Therapeutics N.V. PRQR|Consensus forecast of earnings per share growth for next year Codexis, Inc. (CDXS)|SGMO - Net earnings per share growth forecast for next year|nautilus.bio - Projected earnings per share increase next year|Metagenomi, Inc (MGX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year DTIL|Net earnings per share growth forecast for next year Generation Bio|Earnings growth forecast for next year Boundless Bio Inc|Net earnings per share growth forecast for next year Exicure Corp (XCUR)|Consensus forecast of earnings per share growth for next year Imunon|Earnings growth forecast for next year PHIO (phiopharma.com)|Net earnings per one share growth forecast for next year mustangbio.com|RNAZ - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Bionano Genomics|APDN: Earnings growth forecast for next year|Expected earnings per share growth for next year ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Earnings growth forecast for next year|Singular Genomics (OMIC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Regulus (RGLS)|SYRS (Syros Pharmaceuticals, Inc) - Expected earnings per share trend next year|Telesis Bio, Inc. - Expected earnings per share growth for next year|TCON: Projected earnings per share growth rate for next year|Unity Biotechnology Inc. - Earnings growth forecast for next year